Clinical trial
Bio-CAR-T Study on Pre and Post-infusion CAR-T Cell Therapy
NCT05366569 is registered in ClinicalTrials.gov with Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bio-CAR-T Study on Pre and Post-infusion CAR-T Cell Therapy
- Lead sponsor
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 26, 2022
- Completion date
- December 31, 2026
- Enrollment
- 45 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia (all), diffuse large b cell lymphoma (dlbcl), primary mediastinal large b-cell lymphoma (pmbcl)